Research & Development
21 October 2025 - Swedish pharmaceutical company XSpray Pharma AB (STO:XSPRAY) said on Tuesday that the US Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for XS003 (nil...
21 October 2025 - Citius Oncology Inc (Nasdaq:CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals Inc (Nasdaq:CTXR), announced on Monday that it has entered into a distribution services a...
21 October 2025 - Cumberland Pharmaceuticals Inc (Nasdaq:CPIX), a US-based specialty pharmaceutical company, announced on Monday that it has entered into strategic arrangements with RedHill Biopharma ...
21 October 2025 - The Lupus Foundation of America Inc reported on Monday that the US Food and Drug Administration (FDA) has approved Gazyva (obinutuzumab), developed by biotechnology company Genentech...
20 October 2025 - Biopharmaceutical company AstraZeneca PLC (LSE: AZN) (STO: AZN) (Nasdaq: AZN) announced on Monday that it has received US Food and Drug Administration (FDA) approval for Tezspire (te...
20 October 2025 - Antengene Corporation Limited (SEHK: 6996.HK), a China-based, commercial-stage global biotech company focused on discovering, developing and commercialising medicines for hematologic...